Litigation

Recent Posts

97 Federal Cases Alleging Cancer From Diabetes Drugs Centralized In MDL
Posted on 27 Aug 2013 by Tom Moylan

WASHINGTON, D.C. — (Mealey’s) Ninety-seven federal lawsuits in which plaintiffs allege that three incretin-based diabetes drugs caused their pancreatic cancer were centralized Aug. 26 by a federal judicial panel into a multidistrict litigation... Read More

Tags: Novo Nordisk Inc. , California , Januvia , Victoza , Byetta , U.S. District Court for the Southern District of California , diabetes drugs , pancreatic cancer , Litigation , multidistrict litigation , Merck Sharp & Dohme Corp. , Eli Lilly and Co. , In Re: Incretin Mimetics Products Liability Litigation , Amylin Pharmaceuticals , MDL

Lawsuits Follow Diabetes Drug Actos' Link To Cancer Risk
Posted on 9 Aug 2011 by LexisNexis Litigation Resource Community Staff

TRENTON, N.J. - (AP) The maker of the world's best-selling diabetes drug is facing hundreds of lawsuits and likely a big sales drop as suspicion grows that taking the pill for more than a year raises the risk of bladder cancer. In June, Takeda Pharmaceuticals... Read More

Tags: diabetes drug , lawsuits , European Medicines Agency , Weitz &amp , Food and Drug Administration , Luxenberg , Actos , Januvia , Type 2 diabetes , FDA , bladder cancer , Vioxx , Diabetes Care , Merck , Litigation , diabetes , Avandia